Effects of palytoxin on Na, K and ATP contents of vascular smooth muscle of rabbit aorta. 1984

H Ozaki, and H Nagase, and K Ito, and N Urakawa

Palytoxin (PTX) at concentrations higher than 10(-9) M increased tissue Na and decreased tissue K contents in the smooth muscle of rabbit aorta. The decrease in the tissue K content induced by PTX (10(-8)M) was complete within 1 hr. Saponin (1 mg/ml) and Triton X-100 (0.1% wt./vol.) also rapidly decreased the tissue K content. On the other hand, a high concentration of ouabain (10(-3)M) did not change the tissue K content within 1 hr of application, and the maximum loss of K was obtained after 6 hr. Loss of tissue Na into Na- and K-free solution from Na loaded muscle was accelerated by PTX (10(-8)M). The PTX-induced increase in loss of Na was inhibited in proportion to the decrease in the temperature from 37 to 10 degrees C, while the loss of Na in the absence of PTX was almost completely inhibited at 24 degrees C. Decrease in the wet weight of the muscle induced by hyperosmotic solution was inhibited by pretreatment with PTX (10(-8)M) or saponin (1 mg/ml) for 1 hr. PTX (10(-9) and 10(-8)M) had no effect on the ATP content of the muscle. However, PTX at concentrations above 10(-7)M reduced the ATP content, and a significant amount of ATP was detected in the incubation medium. Saponin (1 mg/ml) and Triton X-100 (0.2% wt./vol.) induced a release of Na from liposomes prepared with synthesized lecithin or total lipids of rabbit red blood cells. However, no Na leak was induced by PTX (10(-8)-10(-6)M) in these liposomes. These results suggest that PTX at low concentrations (10(-9)-10(-8)M) increases the membrane permeability of vascular smooth muscle cells to Na and K ions. At higher concentrations (10(-7)-10(-6)M). PTX seems to form pores which are permeable to a larger molecule like ATP. The results further suggest that the mode of action of PTX is different from that of saponin or detergent.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003064 Cnidarian Venoms Venoms from jellyfish; CORALS; SEA ANEMONES; etc. They contain hemo-, cardio-, dermo- , and neuro-toxic substances and probably ENZYMES. They include palytoxin, sarcophine, and anthopleurine. Chironex Venoms,Jellyfish Venoms,Nematocyst Venoms,Sea Anemone Venoms,Chironex Venom,Cnidarian Venom,Jellyfish Venom,Portuguese Man-of-War Venom,Sea Anemone Venom,Portuguese Man of War Venom,Venom, Chironex,Venom, Cnidarian,Venom, Jellyfish,Venom, Portuguese Man-of-War,Venom, Sea Anemone,Venoms, Chironex,Venoms, Cnidarian,Venoms, Jellyfish,Venoms, Nematocyst,Venoms, Sea Anemone
D000178 Acrylamides Colorless, odorless crystals that are used extensively in research laboratories for the preparation of polyacrylamide gels for electrophoresis and in organic synthesis, and polymerization. Some of its polymers are used in sewage and wastewater treatment, permanent press fabrics, and as soil conditioning agents.
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas

Related Publications

H Ozaki, and H Nagase, and K Ito, and N Urakawa
March 1993, Diabetologia,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
March 1988, Japanese journal of pharmacology,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
April 1986, The American journal of physiology,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
July 1981, European journal of pharmacology,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
January 1989, Archives internationales de pharmacodynamie et de therapie,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
December 1980, European journal of pharmacology,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
June 1989, Masui. The Japanese journal of anesthesiology,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
April 1998, The Journal of membrane biology,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
January 2003, Journal of cardiovascular electrophysiology,
H Ozaki, and H Nagase, and K Ito, and N Urakawa
December 1997, British journal of pharmacology,
Copied contents to your clipboard!